Clinical Trials Browser

INDUSTRY × Neoplasms × HMPL-013 × Clear all

NCT01645215 2020-02-17

Phase I Study of Fruquintinib(HMPL-013) in Patients With Advanced Solid Tumors

Phase 1 Completed

Neoplasms